Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
The current price of Eli Lilly And Co in the market is 46 137,24 ₴, with a 24-hour trading volume of 86,17B ₴. The asset's market cap is 41,14T ₴, after moving 2.43% in the last day.
Tokenized Eli Lilly And Co is trading at 46 306,56 ₴, with a tokenized market cap of 261,08M ₴ and a 24-hour trading volume of 94,58M ₴. The tokenized asset has moved 3.73% in the past 24 hours.